Zika virus NS2B-NS3 protease (ZIKV NS2B-NS3pro)

The Zika virus NS2B-NS3 protease is a serine protease essential for viral replication and represents a major therapeutic target for Zika virus infection. This enzyme is composed of two components: a cytosolic ~48-50 amino acid region of the membrane-anchored NS2B protein and the N-terminal ~170 amino acid domain of the NS3 protein (NS3pro). The catalytic triad consists of three residues: His51, Asp75, and Ser135, located in the N-terminal region of NS3. Unlike typical serine proteases that contain a single polypeptide chain, the flavivirus protease requires the formation of the NS2B-NS3 complex for proper enzymatic function. NS2B plays multiple indispensable roles: it is critical for the folding of NS3 (which is insoluble or unstructured when expressed alone), its molecular interaction with the substrate is essential for enzymatic activity, and its membrane localization positions the protease complex near cleavage sites on the endoplasmic reticulum membrane where the viral replication complex forms. The protease is responsible for all cytoplasmic cleavages of the viral polyprotein, including junctions between NS2A/NS2B, NS2B/NS3, NS3/NS4A, and NS4B/NS5, as well as processing structural proteins. This processing is absolutely required for viral maturation and assembly. Recent structural studies have revealed that NS2B-NS3 protease adopts multiple conformations: a proteolytically active "closed" conformation, an "open" conformation that appears to bind single-stranded RNA with a dissociation constant of approximately 0.3 μM, and a "super-open" conformation. This conformational flexibility suggests a dual function, with the protease cycling between conformations to enable both proteolytic activity and RNA binding as part of a tightly intertwined helicase-protease machinery. The NS2B-NS3 protease is highly conserved among flaviviruses, making it an attractive target for developing broad-spectrum antiviral drugs. Its critical dependence for viral propagation and its unique structural features compared to host proteases make it a promising therapeutic target for treating Zika virus infection and potentially other flavivirus infections including Dengue, West Nile, and related viruses.

Other names

NS2B-NS3 serine proteaseZIKV proteaseZika virus proteaseNS2B/NS3 proteaseNS3 protease

Competitive inhibition at the active site. Allosteric inhibition targeting the "super-open" conformation. Substrate-mimetic inhibition. Prevention of viral polyprotein processing. Inhibition of viral replication.